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Growth is a polygenic trait that is under the influence of multiple physiological pathways regulating energy metabolism and 
muscle growth. Among the possible growth-regulating pathways in vertebrates, components of the somatotropic axis are 
thought to have the greatest influence. There is growing body of literature focusing on the somatotropic axis and its role regu-
lating growth in fish. This includes research into growth hormone, upstream hypothalamic hormones, insulin-like growth fac-
tors, and downstream signaling molecules. Many of these signals have both somatic effects stimulating the growth of tissues 
and metabolic effects that play a role in nutrient metabolism. Signals of other endocrine axes exhibit profound effects on the 
function of the somatotropic axis in vivo. In this review we highlight recent advances in our understanding of the teleost fish 
endocrine somatotropic axis, including emerging research using genetic modified models. These studies have revealed new 
aspects and challenges associated with regulation of the important steps of somatic growth. 
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Somatic growth reflects the balance between food intake 
and all other physiological activities. It is a polygenic trait 
that is regulated by several physiological pathways that are 
responsive to environmental and nutritional status and in-
volved in energy metabolism and reproduction [1]. The 
growth hormone-insulin-like growth factor (GH-IGF) 
sys-tem, normally characterized as two core components of 
the somatotrophic endocrine axis, plays a major role in co-
ordinating the growth of vertebrates, including fish. Re-
search into the regulation of fish growth has focused on the 
production and secretion of growth hormone (GH) from the 
pituitary. However, the GH-IGF system also includes GH 
binding proteins (GHBP), GH receptors (GHR), IGF bind-
ing protein (IGFBP), and IGF receptors (IGFR) [2,3]. The 
GH-IGF system of fish is particularly interesting and com-
plex because it consists of multiple subtypes of GHRs, 
IG-FRs, and IGFBPs that arose through gene duplication 
events associated with the evolution of the teleost lineage 
[4,5]. Peripheral regulation of the GH-IGF system results 
from adjustment of the peripheral sensitivity to GH and 
IGFs, as well as by modulating the bioavailability and ac-
tions of GH and IGFs in target cells. These components are 
widely distributed and they interact to coordinate both 
growth and a range of other biological processes such as 
metabolism, osmoregulation, reproduction, behavior, and 
immunity. A number of chemicals, including hormones 
such as growth hormone releasing hormone (GHRH), insu-
lin, somatostatin, and sex steroids, and a variety of tran-
scription factors, proteases, and phosphatases, regulate the 
synthesis and activity of GHRs, GHBPs, IGFRs, and 
IGFBPs and the synthesis, secretion, and bioavailability of 
IGFs. Additionally, a number of environmental factors (e.g., 
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nutritional state, photoperiod, stress, and temperature) can 
have a significant effect on the expression and activity of 
peripheral components of the GH/IGF system [1,4].   
The endocrine regulation of growth and metabolism is 
interrelated. Many of the endocrine factors involved in the 
regulation of somatic growth are involved in lipid and pro-
tein metabolism, which in turn play a role in nutrient utili-
zation, immune system function, and reproduction. The 
complex regulation of these system components appears to 
be both organism- and tissue-specific [6]. This review will 
synthesize recent work on the somatotropic endocrine axis 
of fish, including endocrine regulation of pituitary GH and 
extrapituitary aspects of the GH-IGF system.  
1  Components of the endocrine somatotropic 
axis 
1.1  Growth hormone 
GH is a pluripotent hormone produced primarily by the pi-
tuitary gland in teleosts, as in other vertebrates. In fish, GH 
transcripts have been identified in a number of tissues other 
than the pituitary, including the gill, brain, kidney, liver, 
pyloric caeca, ovary, skeletal muscle, heart, and spleen. 
This widespread distribution suggests GH has a number of 
roles in teleosts, including osmoregulation and reproduction 
[7,8]. Binding of growth hormone to the receptor leads to 
receptor dimerization and the activation of an intra- and 
intercellular signal transduction pathway, leading to growth. 
The Janus kinase/signal transducers and activators of the 
transcription (JAK/STAT) pathway are thought to be the 
primary downstream signaling cascade for GH. Two forms 
of GHRs have been identified in many fish species, and are 
most abundant in the liver, gonad, kidney, muscle, pituitary 
and spleen [9].  
In 1985, Zhu et al. [10] demonstrated that GH promoted 
teleost growth using human GH transgenic goldfish. Incor-
poration of the GH transgene induced a number of direct 
effects on several tissues, including an increase in IGF-1 
and IGF-2 mRNA expression in a range of organs [8,11]. 
This suggests that IGF-1 and IGF-2 may be the primary 
downstream mediators of the growth effects of GH, con-
sistent with observations in all other vertebrates. However, 
the growth enhancing effect of the GH transgene in fish 
appears to be dependent on the genetic background [12]. 
Unlike hemizygote GH transgenic fish, homozygote 
GH-transgenic zebrafish, that have double the levels of the 
GH transgene, did not exhibit significant enhancement of 
growth. This is thought to be a result of an increase in the 
level of negative feedback within the GH pathway, probably 
inhibited by the signals, such as suppressors of cytokine 
signaling 1 (socs1) and socs3 [13].  
Observations of GH morphants have revealed that GH is 
not involved in the regulation of growth and development 
during early life history stages in zebrafish [14]. Decreased 
somatic growth and increased adipose tissue accumulation 
have been observed in zebrafish gh1 mutants. However, the 
expression levels of all IGF transcripts, including IGF-1, 2a, 
2b, and 3, remained unchanged in the whole fish gh1 mu-
tants compared with those in wild-type siblings [15]. These 
observations highlight the range of roles fish GH plays in 
the regulation of growth and lipid metabolism. Kuradomi et 
al. [16] also reported that the muscle hypertrophy resulting 
from GH over-expression in zebrafish was independent of 
local IGF-1 expression. Thus, further studies seems to be 
needed for learning more about the tissue- and stage-   
specific patterns and effects of IGFs expression in gh1 null 
zebrafish. Historical evidence supports the hypothesis that 
the somatogenic action of GH is mediated by the hepatic 
generation of endocrine IGF-1, though more recent data 
demonstrate that GH also has a direct effect on growing 
tissues. The contribution of GH via the action of IGFs to the 
regulation of body growth continues to be a subject of con-
troversy.  
1.2  Insulin-like growth factors 
IGFs are proteins that have high sequence similarity to insu-
lin but with the addition of an extra D-domain [4]. In 
mammals, IGFs are primarily secreted by the liver follow-
ing stimulation by GH. IGF-1 expression is essential to 
achieve maximal growth in mammals, whereas IGF-2 is 
thought to be a primary growth factor regulating early de-
velopment. Loss of IGF-1 or IGF-2 in knock-out mice re-
sults in significant loss of body weight [17,18], while 
over-expression of IGF-1 or IGF-2 causes somatic 
over-growth in mammals [19,20]. The IGFs bind to IGF 
receptors, insulin receptor, insulin-related receptor, and 
possibly other receptors. These receptors are expressed in a 
range of tissue types, suggesting that IGFs have a range of 
functions. In vivo, IGFs are also regulated by a family of 
proteins known as the IGFBPs. These proteins help to mod-
ulate IGF action in complex ways that involve both inhibit-
ing IGF action by preventing binding to the IGF receptors, 
or promoting PGF action by promoting delivery to the re-
ceptor and increasing the stability of IGFs [4].  
Most studies of IGFs in fish have focused on identifica-
tion of the genes or development of assays to measure the 
levels of IGFs in tissue and plasma. These studies have 
shown that the structure, regulation, and functions of IGFs 
are similar between fish and mammals [21]. Liver tissue 
contains the greatest concentration of IGF-1 mRNA in trout 
[22] and gill tissue contains the highest abundance of IGF-1 
receptor A (IGF-1RA) mRNA [23]. The type I IGF receptor 
has been identified in several other tissues in adult fish, in-
cluding brain, liver, gastrointestinal tract, ovaries, and mus-
cle [24]. The tissue production of IGF-1 and the presence of 
recep-tors in various tissues suggests it has both paracrine 
and autocrine organ-specific functions in fish. 
Treatment of fish with IGF-1 stimulates growth via mi-
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togenesis promotion [25]. Genetic over-expression of igf-1 
and igf-2 causes dorsalization of embryos characterized by 
an increase in the size of the anterior neural structures 
[26,27]. Knockdown of igf-2a or igf-2b results in ventrali-
zation of embryos with reduced growth, reduced sizes of 
eyes, disrupted brain structures, and a disrupted cardiovas-
cular system, with IGF-2b playing a more significant role in 
development. During gastrulation, IGF-2a and IGF-2b are 
required for development of anterior neural structures and 
for regulation of genes critical to dorsal-ventral patterning. 
As development proceeds, IGF-2a and IGF-2b play an-
ti-apoptotic roles [28]. These observations suggest that fish 
IGFs play a critical role in neural induction as well as 
growth regulation. IGF-1 receptors (IGF-1R) are more 
abundant in fish than the insulin receptor (IR) [29], sug-
gesting that IGF-1 plays a greater role in the regulation of 
muscle function than does insulin in fish. In contrast to 
mammals, specific inhibition of IGF-1R signaling results in 
reduced body size, retarded development, and increased 
embryonic lethality in teleosts [30]. During the adult stage, 
the expression of IGF-1Rs in tissue is responsive to envi-
ronmental factors, including nutritional state and tempera-
ture [31]. Studies in a range of fish species have also 
demonstrated that blood IGFBP levels fluctuate in response 
to switches between anabolic and catabolic states. Recent 
work by Duan and colleagues [3234] has shown that 
knockdown of IGFBPs in zebrafish has profound effects on 
the development of multiple tissues during embryonic and 
early stages. Taken together, these observations demonstrate 
that fish IGFBPs are expressed in spatially and temporally 
restricted patterns, and each IGFBP plays a distinct role in 
regulating developmental processes.  
IGF-1 and IGF-2 have dramatic effects on muscle growth, 
protein synthesis, and myoblast proliferation in fish [35,36]. 
However, our understanding of IGFs function on the regula-
tion of skeletal muscle growth in teleost fish is based pri-
marily on studies of myogenic cells in vitro [4]. Few studies 
have evaluated the regulatory roles of teleost IGFs using in 
vivo models. Recently, we created a mylz2: IGF-1 
trans-genic crucian carp (Carassius auratus) that overex-
pressed zebrafish IGF-1 in skeletal muscle. We observed 
significantly enhanced levels of muscle hyperplasia in 
IGF-1 transgenic fish. Interestingly, however, when IGF-1 
transgenic fish were raised in the same tank as control fish, 
we observed a significant loss in skeletal muscle mass 
compared with the control fish. Additionally, there was a 
shift in production of white muscle toward more oxidative 
red muscle [37,38], together with increased oxygen con-
sumption rates in the IGF-1 transgenic fish. These results 
provide an excellent in vivo model for a global understand-
ing of the effects of teleost IGF-1 on myogenic cell differ-
entiation and proliferation and energy homeostasis in tele-
osts. Using this model, we confirmed that IGF-1 has a mi-
togenic effect on fish skeletal muscle growth and plays a 
role in the regulation of muscle differentiation. Thus, the 
overall phenotype of these IGF-1 transgenic fish is influ-
enced by multiple intrinsic factors, such as endo-
crine/autocrine signals, the flow of nutrients, the rates of 
metabolic processes, and energy budgets [39]. 
1.3  Growth hormone-releasing hormone (GHRH) 
The existence of a GH-releasing factor in hypothalamic 
extracts was first observed in the 1960s [40]. However, it 
was not until 1981 that a neurohormone peptide, with the 
ability to stimulate GH release, was first isolated from pan-
creatic tumor tissue of acromegaly patients [41]. Subse-
quently, this pancreatic hormone was shown to be identical 
to the hypothalamic neurohormone GHRH [42]. In mam-
mals, GHRH is a 44-aa polypeptide. The primary function 
of mammalian GHRH is to stimulate GH release from pitu-
itary somatotrophs upon binding to a specific GHRH re-
ceptor (GHRH-R) that belongs to the seven-transmembrane 
class of G-protein coupled receptors (GPCRs). Additionally, 
mammalian GHRH exhibits multiple extrapituitary func-
tions, such as cell proliferation activation, sleep cycle regu-
lation, cell differentiation regulation, and promotion of 
wound healing [43]. The first fish cDNAs encoding GHRH 
were identified in 2007 in both zebrafish and goldfish. The 
27-aa fish GHRH mature peptides exhibit 81.5% homology 
with human GHRH [44]. Until recently, the GHRH/ 
GHRH-R system has only been documented in a few tele-
ostean species, including zebrafish, goldfish, olive flounder, 
Fugu, medaka, rainbow trout, half-smooth tongue sole, and 
orange-spotted grouper [44–47]. These fish ghrhs are ex-
pressed at high levels in the hypothalamus, telencephalon, 
spinal cord, and at a relative low level in the ovary. Simi-
larly, their specific receptors, ghrh-rs, are abundant in the 
hypothalamus, telencephalon, spinal cord, diencephalon, 
and pituitary, but only present at low levels in the ovary 
[44,47]. Based on our recent pituitary transcriptome studies, 
the levels of both ghrh and ghrh-r expression were less than 
1 RPKM in the zebrafish pituitary at both 45 and 90 d 
post-fertilization (dpf) [48]. Both ghrh and ghrh-r are ex-
pressed in the head region of zebrafish during the embryon-
ic stage. Functional studies indicate that teleostean GHRH 
plays a role in stimulating GH release, immunity regulation, 
and sexual growth dimorphism. GHRH-induced stimulation 
of GH secretion in fish is mediated by both the adenylate 
cyclase/cAMP/ protein kinase A pathway and the nitric ox-
ide/nitric oxide synthase pathway [4447,49]. Inhibition of 
GHRH translation during embryonic stages by morpholino 
oligo (MO) did not result in any obvious developmental 
defects or effects on zebrafish gh expression patterns (our 
unpublished data). Recently, a 66-bp deletion in the 
5′-flanking region of largemouth bass GHRH gene was as-
sociated with recessive embryonic lethality. However, the 
levels of ghrh and gh expression were not reported in the 
null mutant largemouth bass [50]. Because of its role in the 
regulation of GH release, there is interest in understanding 
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the factors controlling GHRH expression. Unfortunately, 
little is known about the regulation of GHRH expression. In 
mammals, substance P (a member of the tachykinins family) 
and clonidine (an α2-adrenergic agonist) have been shown 
to induce GHRH expression [51,52]. The immune-related 
induction of GHRH expression has been reported in or-
ange-spotted grouper (Epinephelus coioides) and olive 
flounder (Paralichthys olivaceus) following Chitinase and 
Edwardsiella tarda infection, respectively [45,53].  
1.4  Pituitary adenylate cyclase-activating polypeptide 
(PACAP) 
PACAP was first identified from the ovine hypothalamus as 
a factor with the ability to stimulate cAMP formation in rat 
anterior pituitary cells [54]. PACAP can stimulate GH, 
gonadotropin, prolactin (PRL), and somatolactin (SL) se-
cretion in teleosts [55,56]. In mammals, GHRH and PACAP 
are encoded by separate genes, whereas PACAP-related 
peptide (PRP) and PACAP are present in the same tran-
script [57]. The duplicate PRP/PACAPs genes and receptors 
have been identified in zebrafish [58], rainbow trout [59], 
and other fish species [5,46]. PACAP and GHRH are highly 
conserved between fish and humans, suggesting they have 
evolutionarily important physiological functions. Despite 
being encoded by the same transcript, the pattern of fish 
PRP and PACAP conservation differs significantly. There is 
a high level of variation between the PRPs of different fish 
species [46]. Like GHRH, PRP and PACAP are also classi-
fied as members of the glucagon superfamily [56]. Interest-
ingly, pacap mRNA levels are approximately 1000-fold 
higher than those of GHRH in fish, particularly in brain 
tissue, but also in other organs. Functional studies have re-
vealed that PACAP plays a pivotal role in all organs or tis-
sues in which this superfamily is expressed [60]. Normally, 
pacap mRNA can be detected at the mid gastrula stage dur-
ing embryogenesis in fish. Knock-down of PACAP in em-
bryos causes morphological defects in specific brain regions 
without affecting GH expression patterns during zebrafish 
adenohypophysis development [61]. Additionally, PACAP 
is involved in the neuroendocrine control of food intake and 
acts as an anorexigenic peptide to regulate satiety in fish 
[62]. PACAP is distributed in a range of tissues in mammals 
and is involved in the regulation of gut motility, airway di-
lation, immune response, steroid production, and insulin 
secretion [55]. However, most of these physiological roles 
have yet to be documented in fish, with the exception of a 
role in reproduction [63]. The expression of PACAP in fish 
is affected by environmental temperature and developmen-
tal stage. PACAP levels increase as a result of excessive 
feeding or refeeding after a period of food-deprivation 
[64,65]. Conversely, PRP-PACAP expression can be sig-
nificantly down-regulated by increasing the level of dietary 
lipids [66]. These observations suggest that PACAP is in-
volved in regulating food intake and somatic growth in fish. 
1.5  Growth hormone inhibiting hormone (GHIH, or 
somatostatin, SST) 
Somatostatin (SST) was initially discovered because of its 
inhibitory effect on GH secretion in the sheep hypothalamus. 
SST was first isolated as a 14-residue peptide (SST-14), 
with a disulfide bridge that allows its cyclic structure [67]. 
Transcription of the SST gene leads to the synthesis of a 
pre-prohormone of SST (PPSST), which can codify various 
SST-related peptides. SST1 and SST2 have been character-
ized in all vertebrates to date. Additional SST genes have 
also been documented in teleosts, including SST3, SST4, 
and SST5. Most recently, a SST-6 gene was isolated in 
zebrafish [68]. The two forms of the mature peptides, 
SST-14 and SST-28 peptides, can be produced by the pro-
cessing of PPSST1 in mammals and some teleost fish [69]. 
SST-14 is predominantly produced in the central nervous 
system (CNS) as well as in many peripheral organs. SST-28 
is synthesized primarily by mucosal epithelial cells along 
the gastrointestinal tract (GIT). Alternate forms of the 
SST-14 peptide containing a Pro2 residue (Pro2-SST-14) 
are derived from PPSST-2 [70]. Other forms of SST pep-
tides are derived from PPSST-3 and PPSST-4 and have also 
been found in teleost fish [71,72]. All of these mature SST 
peptides are located at the C-terminal of SST precursors 
[72]. In mammals, SST inhibits most pituitary hormone 
secretions, including GH and PRL. Generally, SST has an 
inhibitory effect on basal and/or GHRH- and ghrelin-  
stimulated GH release [73]. However, a moderate increase 
in plasma GH levels and a significant decrease in pituitary 
GH content have been observed in SST null mice. Despite 
the changes in plasma and pituitary GH, there is no signifi-
cant difference in plasma IGF-1 levels and body length be-
tween wildtype and SST null mice [74]. Taken together, 
these observations suggest that, although SST has an im-
portant inhibitory effect on GHRH, it plays a less prominent 
role in maintaining baseline GH secretion in the mouse pi-
tuitary. Moreover, low levels of SST can even stimulate GH 
release from somatotrophs via binding to SST receptor 5 
(SSTR5). The concentration-dependent, dual effects of SST 
on GH release have been reported in primary cultures of 
pituitary cells from swine and baboons [75,76]. The recep-
tors for SST peptides are classified as Class A G pro-
tein-coupled receptors (GPCRs). SST receptors (SSTR) are 
typically classified as 7 trans-membrane domain (TMD) 
receptors. Five SSTR subtypes have been identified in most 
mammals, all of which bind endogenous SST and cortistain. 
These receptors are ubiquitously and differentially ex-
pressed in the SST-producing organs, including the blood 
vessels, muscle, cartilage, bone, and pituitary. Using gene 
targeting data, researchers have identified an important 
neuromodulatory role for SSTR2 in the mouse striatum and 
metabolic abnormalities in SSTR5 null mice associated with 
obesity and insulin resistance [77,78].  
Exogenous administration of SST-14 reduces basal GH 
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secretion in goldfish, rainbow trout, tilapia, and Chinook 
salmon [7981]. The inhibitory effect of SST-14 on GH 
secretion was clearly demonstrated in several in vitro ex-
periments [82,83]. However, the influence of circulating 
SST on the control of GH secretion has not been clearly 
addressed in fish. The regulation of GH by SST may be 
influenced by developmental stage, feeding, and nutritional 
state [84,85]. Other research suggests that SSTs are in-
volved in the regulation of growth hormone sensitivity of 
fish hepatocytes, and can cause a reduction in the levels of 
GHR expression and IGF-1 biosynthesis and secretion 
[86,87]. SSTR2 activation is linked to inhibition of pituitary 
GH release in fish [88]. Additionally, there is an inverse 
correlation between SST plasma levels and thyroid hormone 
levels in fish [89]. Recently, we observed mortality prior to 
20 dpf as a result of severe developmental defects in SSTR5 
null zebrafish that had up-regulated gh and prolactin mRNA 
levels compared with wild-type larva (unpublished data).  
1.6  Other neuropeptides and neurotransmitters 
The neuroendocrine-regulation of GH is also influenced by 
a group of neurotransmitters and neuropeptides at the hy-
pothalamic and suprahypothalamic levels. As a result GH 
secretion is influenced by hypophysiotropic and exogenous 
and endogenous factors. The complexity of these regulatory 
networks stems from the abundance of different neuro-
transmitter and neuropeptide neurons present in the hypo-
thalamus. Therefore, many of the effects are status-    
dependent (e.g., developmental stage or nutritional status). 
Decreased levels of serum GH have been reported after in-
traperitoneal injection of norepinephrine (NE). Additionally, 
both NE and serotonin (5HT) inhibit GH secretion from 
goldfish pituitary cells cultured in vitro [2]. In vivo admin-
istration of a glutamate agonist, N-methyl-D-aspartate 
(NMDA), inhibits GH secretion in goldfish, an effect that is 
enhanced by estradiol (E2) treatment [90]. However, 
NMDA also stimulates GH secretion in steroid-primed im-
mature rainbow trout [91,92]. Gamma-aminobutyric acid 
(GABA) inhibits GH secretion in vivo but not in vitro, sug-
gesting an indirect action, likely by inhibiting the secretion 
of hypothalamic factors such as dopamine [93].  
Glucocorticoids have no positive effect on GH expres-
sion, whereas thyroid hormone and retinoic acid stimulate 
GH expression in pituitary cells from common carp and 
Atlantic salmon [94]. Norepinephrine and epinephrine sup-
press basal GH release from goldfish pituitary cells in a 
reversible and dose-dependent manner. Salmon gonadotro-
pin-releasing hormone (sGnRH) and dopamine, two known 
GH-releasing factors in fish, stimulate GH release from 
goldfish pituitary cells and their GH-releasing actions are 
inhibited by simultaneous treatment with norepinephrine. 
This effect, however, is not altered by the beta agonist 
iso-proterenol and α1 agonist methoxamine [95].  
Sex steroids also modulate the expression of the core 
components of the somatotropic axis. Intrapituitary regula-
tors, including gonadotropin and inhibin/activin, provide 
autocrine/paracrine control over GH synthesis and secretion 
[96]. In rainbow trout, estrogen treatment significantly re-
duces food conversion, body growth, and the expression of 
GHRs, IGFs, and IGFRs [97]. At the somatotroph level, 
receptor expression of a multitude of neuroendocrine factors 
integrates the signals from various regulators [96]. Ghrelin 
was first identified and characterized from the rat stomach 
as an endogenous ligand of the growth hormone secreta-
gogue receptor. Ghrelin is essential for initiation of gh ex-
pression in the zebrafish adenohypophysis [98]. Both forms 
of GHSHR-1a and -1b are found in the pituitary of tilapia. 
Intraperitoneal injections of Ghrelin significantly increase 
plasma GH levels and hepatic expression of ifg-1 and ghr in 
tilapia [99]. Hepatic expression of coho salmon igf-2 can 
also be regulated by metabolic hormones, such as insulin, 
dexamethasone, glucagon, and triiodothyronine (T3) [100]. 
The expression of igf-1 in cultured hepatocytes of silver sea 
bream is significantly increased by incubation with T4, but 
not T3. Conversely, the expression of ifg-1 is significantly 
decreased in hepatocytes in a dose-dependent manner by 
incubation with cortisol (1–1000 ng mL1) [101]. 
2  Balance between of somatic growth and me-
tabolism 
GH or IGF-1 overexpression increases skeletal myocyte 
mitogenesis and consequently increases the metabolic rate 
in fishes and elevates levels of oxygen consumption 
[39,102]. The elevation of GH levels in GH-transgenic 
common carp may influence food intake and feeding be-
havior by up-regulating the hypothalamic orexigenic factor, 
agouti-related peptide 1 [103]. Oxygen uptake by GH 
transgenic common carp fish increases as a result of feeding, 
not because of an increase in basal metabolism [104]. The 
elevated basal levels of oxygen consumption during IGF-1 
overexpression in crucian carp may result from hyperplasia 
and cellular changes in the skeletal muscle [39]. 
In yearling coho salmon subject to different feeding re-
gimes, basal levels of insulin are relatively constant after 
various periods of fasting, whereas those of IGF-I, IGFBPs, 
and GH changed in proportion to the duration of the fast. A 
single meal causes rapid increased but moderate levels of 
IGF-I 2 h after the meal, but only in the regularly fed fish. 
GH levels decreased after the meal to the same extent 
among groups regardless of the fasting period. Thus, the 
basal levels of IGF-I adjust to the long-term nutritional sta-
tus and are less responsive to acute nutritional input. 
IGFBPs maintain their sensitivity to food intake, even after 
prolonged fasting, suggesting they play a critical role in the 
nutritional regulation of salmon growth [105]. In the fine 
flounder, a flatfish with remarkably slow growth, plasma 
GH levels remain stable and relatively high in comparison 
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with other teleost species. Plasma GH levels are signifi-
cantly elevated by 2-weeks fasting. At the onset of refeed-
ing, plasma GH levels decline following a single meal. Thus, 
plasma GH levels in the fine flounder are strongly linked to 
nutritional status [106]. In contrast to the direct effects of 
GH on growing tissues, the systemic effects mediated by 
hepatic IGFs are influenced by environmental and nutri-
tional status. Both insulin and thyroid hormones are also 
significantly affected by nutritional status, and both these 
hormones are required for correct expression of hepatic 
GHR and GH-signal transduction. This also appears to be 
the case in fish, as insulin potentiates the in vitro stimulato-
ry action of GH on IGF-1 transcription [107].  
In addition to growth promotion, GH also regulates lipid 
mobilization. During periods of food deprivation, growth is 
inhibited by lipid depletion. Fasting of rainbow trout for 2 
or 6 weeks results in reduced growth and elevated plasma 
GH. Sensitivity to GH in the liver is also reduced in fasting 
fish and is associated with reduced levels of ghr1 and ghr2 
transcripts. However, the sensitivity to GH in adipose tissue 
increases in fasting fish that exhibit lipid depletion [108]. 
The sizes of fat deposits are significantly increased in gh 
mutants relative to wild type zebrafish. These observations 
suggest that GH1 signaling restricts adipose tissue hyper-
trophy in zebrafish. Lastly, nutrient deprivation of gh mu-
tants is associated with decreased adipose tissue mobiliza-
tion during caloric restriction, further implicating the role of 
GH1 signaling in maintaining adipose tissue homeostasis 
[15].  
Research conducted primarily in salmonids suggests that 
GH plays a critical role in seawater adaption as there is a 
clear correlation between elevated GH and growth and 
iso-osmotic salinity exposure. Changes in water temperature 
modulate fish GH, levels being highest during the warmer 
seasons of the year. Environmental pollutants, including 
xenoestrogens and heavy metals, also affect GH mediated 
mechanisms in fish, possibly via interference with the GH 
receptor and/or GH transcription. Additionally, common 
stressors in aquaculture such as handling, confine-
ment/overcrowding, and nutritional stress also affect GH 
levels [109]. 
3  Interaction between the endocrine regula-
tions on somatic growth and reproduction 
Sexual maturation and decreased somatic growth are asso-
ciated with adolescent development, a process that is con-
trolled by the interconnected neuroendocrine regulatory 
pathways of the endogenous endocrine system. However, 
the crosstalk between the networks involved in the somato-
trophic endocrine axis and reproductive axis is complex. 
For example, GHR is expressed in fish gonadal tissue [110] 
and potentiates the vitellogenesis stimulating effect in eel 
primary hepatocytes [111]. GH also stimulates E2 synthesis 
by ovarian tissue in killifish (Fundulus heteroclitus) [112] 
and spotted seatrout (Cynoscion nebulosus) [113]. IGFs are 
also expressed in the testis and ovary of several fish species 
[114116]. IGF-1 and/or IGF-2 may serve as para-
crine/autocrine regulators of fish spermatogenesis in the 
testis, and promote proliferation and oocyte maturation in 
the ovaries [116118]. The function of gonadal IGF-3 may 
be limited to the male gonads. The GH-responsiveness of 
gonadal IGF-1 and IGF-2 is dependent on gonad develop-
mental stage. The gonadal expression of igf-3 is not regu-
lated by GH signals, but by estrogen and/or gonadotropin 
[116,119]. IGFR1b is essential for zebrafish primordial 
germ cell (PGCs) migration and survival [120]. However, 
estrogen can disrupt post-embryonic growth by reducing 
GH sensitivity, IGF production, and IGF sensitivity in 
rainbow trout juveniles [121]. In tilapia, E2 stimulates vi-
tellogenin production primarily by activation of ERα and 
down-regulation of the GH/IGF-I axis, thus shifting energy 
from somatic growth towards vitellogenesis at the level of 
the liver [122]. Dead end (DND) is an RNA-binding protein 
for that is essential to the survival zebrafish of PGCs. Loss 
of DND results in PGC-null zebrafish developing into infer-
tile males [123]. In our laboratory, we observed a 25% in-
crease in the body weight of PGC-null dnd morphants at 5 
months of age compared with male sibling wildtype control 
zebrafish (unpublished data, Figure 1). This demonstrates 
the balance between the networks regulating somatic 
growth and reproduction  
Analysis of the global gene expression patterns in the 
zebrafish pituitary during the juvenile and sex maturation 
stages revealed that luteinizing hormone β (lhb) is the only 
pituitary hormone transcript to exhibit a significant change 
in expression between 45 and 90 dpf [48]. A decrease in 
spermatic parameters and reproductive success has been 
observed in GH overexpressing zebrafish males [124]. Ad-
ditionally, GH overexpression in grass carp (Ctenopharyn-
godon idellus) females is associated with delayed gonadal 
development, and is accompanied by elevated GH and de-
creased LH levels in serum [103]. These results from in vivo 
models clearly highlight the regulatory balancing of energy 
metabolism between the fish endocrine axes for somatic 
growth and reproduction. 
The rate of somatic growth in fish is the primary trait of 
interest for the majority of aquaculture selection programs. 
As a result, there has been considerable research into under-
standing the factors influencing growth in fish. This body of 
research suggests that the processes controlling somatic 
growth are a consequence of the species-specific evolution-
ary processes. Being a polygenic trait, somatogenesis in fish 
is influenced by appetite, nutrient absorption, metabolism, 
developmental stage, social behavior, and environmental 
factors. Although, individual genes can contribute dispro-
portionately to the production traits of an aquaculture spe-
cies, increased growth can not necessarily be achieved by 
manipulation of single genes. Teleosts are the largest group 
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Figure 1  Increased body weight of germ cell depleted zebrafish. The primordial germ cells (PGCs) of zebrafish were impaired at the embryonic stage by 
injection of dead end (dnd)-specific morpholino oligo (MO). The zebrafish morphants injected with control MO or dnd-MO were raised in the same tank 
until 5 months post-fertilization (mpf). There was a 24.5% increase in body weight in dnd-MO males (0.4956±0.391 g, n=9) compared with the control MO 
males (0.3980±0.0333 g, n=10) (P<0.01). 
of vertebrates with species that occupy a wide range of hab-
itats. Given this, they likely have a range of growth traits 
and regulatory mechanisms. However, endocrinological 
studies of somatic growth in fish are in their infancy relative 
to those in mammals. Additionally, the limited studies to 
date have used a range of species so it is difficult to draw 
general conclusions. To increase our understanding of so-
matic growth and regulation in fish, researchers are in-
creasingly relying on genomic data and using model organ-
isms like zebrafish. 
For many years, zebrafish have served as an important 
tool for understanding vertebrate development and model-
ing of diseases. In recently years, the species has also 
emerged as a highly useful teleost model for studying endo-
crine changes induced by gene targeting techniques, such as 
transcription activator-like effector nucleases (TALENs) 
and CRISPR (clustered regularly interspaced short palin-
dromic repeats)/Cas9(CRISPR-associated system Cas 9) 
[125]. However, it is difficult to perform many classical 
endocrine assays with the zebrafish model because of its 
small body size, limited numbers of zebrafish cell lines, and 
lack of specific antibodies against zebrafish endocrine sig-
nals. As the use of zebrafish models increases, it is antici-
pated that these issues will be addressed. Given the large 
number of teleosts species that have evolved over millions 
of years, zebrafish will not provide insights for all teleost 
species. Additionally, given the increasing importance of 
aquaculture as a means of providing cheap protein, research 
may also need to focus on the principle aquaculture species.  
The goal of the present review was to highlight recent 
advances in our understanding of the neuroendocrine regu-
lation of somatic growth. We have provided a simplified 
illustration of the integrating networks within the endocrine 
somatotropic and reproductive axes in fish (Figure 2). In 
doing so, areas that require more attention can be easily 
identified. Despite the vast body of knowledge that exists 
documenting endocrine regulation of somatic growth of fish, 
the mode of GH/IGFs action and the interactions with the 
hypothalamus-pituitary-gonad (HPG) axis remain poorly 
understood. Generally, little is known about the actions of 
the GH/IGF axis on skeletal and gonadal tissue. The classic 
view posits that hepatic IGF-1 mediates the physiological 
function of GH secreted from the pituitary. The regulatory 
functions of SST on GH secretion, ghrelin, and PACAP 
have been observed in vitro in a range of teleosts. However, 
recent observations utilizing genetic models generated with 
gene targeting techniques have been unable to confirm these 
observations in vivo. Research into the temporal and spatial 
expression of the components of the endocrine somatotropic 
axis and their actions in stage- and tissue-dependent man-
ners will hopefully help explain the mechanisms. Addition-
ally, very little is known about signaling mechanisms for 
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Figure 2  Simplified illustration of the integrating networks of the endocrine somatotropic axis and other endocrine axes in fish. Important protein signals, 
reagents, and activities are represented by black, purple, and dark blue characters, respectively. Thin lines indicate the conclusions based on in vitro work or 
observation following reagent administration. Thick lines indicate the conclusions drawn on studies with in vivo models. Red arrows represent positive regu-
lation. Green bars represent negative regulation. See more details in text.  
crosstalk between the endocrine regulatory signaling 
path-ways of somatic growth and immune responses. Un-
derstanding the relationship between somatic growth and 
other physiological processes is of considerable importance 
to the development of the aquaculture industry. This under-
standing is reliant on increased knowledge of the biology of 
the endocrine somatotropic axis in fish.  
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